which in turn led to what she characterized as a "really early" cancer diagnosis. An MRI revealed a tumor at the T3 area of her spine that engulfed the bone and compressed her spinal cord.

Germany’s Boehringer Ingelheim has made a move to expand its cancer pipeline via a takeover of T3 Pharma, a spinout from the University of Basel in Switzerland. The pharma group is paying CHF ...